Houston Oncology Summit: MD Anderson’s Funda Meric-Bernstam on antibody-drug conjugates
She describes how antibody-drug conjugates have improved over recent years and lists some of her favorite targets and indications that ADCs are going after.
Brought to you by:
Comments